The question of how to explain what artificial intelligence models are doing is emerging as a key regulatory issue in pharmaceutical manufacturing.
The “explainability” of self-learning AI models can be so low, many would sidestep the challenge by treating them more like...
Welcome to In Vivo
Create an account to read this article
Already a subscriber?